标题
The molecular basis of breast cancer pathological phenotypes
作者
关键词
-
出版物
JOURNAL OF PATHOLOGY
Volume 241, Issue 3, Pages 375-391
出版商
Wiley
发表日期
2016-11-17
DOI
10.1002/path.4847
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Alcohol Use and Breast Cancer: A Critical Review
- (2016) Kevin D. Shield et al. ALCOHOLISM-CLINICAL AND EXPERIMENTAL RESEARCH
- Chemokine axes in breast cancer: factors of the tumor microenvironment reshape the CCR7-driven metastatic spread of luminal-A breast tumors
- (2016) Polina Weitzenfeld et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Co-occurrence of MYC amplification and TP53 mutations in human cancer
- (2016) Peter Ulz et al. NATURE GENETICS
- Genefu: an R/Bioconductor package for computation of gene expression-based signatures in breast cancer
- (2015) Deena M. A. Gendoo et al. BIOINFORMATICS
- Comprehensive Molecular Portraits of Invasive Lobular Breast Cancer
- (2015) Giovanni Ciriello et al. CELL
- The prognostic landscape of genes and infiltrating immune cells across human cancers
- (2015) Andrew J Gentles et al. NATURE MEDICINE
- limma powers differential expression analyses for RNA-sequencing and microarray studies
- (2015) Matthew E. Ritchie et al. NUCLEIC ACIDS RESEARCH
- TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis
- (2015) M-F Pang et al. ONCOGENE
- Tumor-Infiltrating Lymphocytes and Associations With Pathological Complete Response and Event-Free Survival in HER2-Positive Early-Stage Breast Cancer Treated With Lapatinib and Trastuzumab
- (2015) Roberto Salgado et al. JAMA Oncology
- Regularization Paths for Generalized Linear Models via Coordinate Descent
- (2015) Jerome Friedman et al. Journal of Statistical Software
- Abstract S1-05: Tumor infiltrating lymphocytes (TILs) indicate trastuzumab benefit in early-stage HER2-positive breast cancer (HER2+ BC)
- (2014) S Loi et al. CANCER RESEARCH
- Prognostic Value of Tumor-Infiltrating Lymphocytes in Triple-Negative Breast Cancers From Two Phase III Randomized Adjuvant Breast Cancer Trials: ECOG 2197 and ECOG 1199
- (2014) Sylvia Adams et al. JOURNAL OF CLINICAL ONCOLOGY
- Molecular Features and Survival Outcomes of the Intrinsic Subtypes Within HER2-Positive Breast Cancer
- (2014) Aleix Prat et al. JNCI-Journal of the National Cancer Institute
- CCL21/CCR7 axis activating chemotaxis accompanied with epithelial–mesenchymal transition in human breast carcinoma
- (2014) Fei Li et al. MEDICAL ONCOLOGY
- FABP7 and HMGCS2 Are Novel Protein Markers for Apocrine Differentiation Categorizing Apocrine Carcinoma of the Breast
- (2014) Pavel Gromov et al. PLoS One
- Lymphovascular invasion and histologic grade are associated with specific genomic profiles in invasive carcinomas of the breast
- (2014) Felipe Fidalgo et al. TUMOR BIOLOGY
- PD-L1 Expression in Triple-Negative Breast Cancer
- (2014) E. A. Mittendorf et al. Cancer Immunology Research
- AQP5 Expression Predicts Survival in Patients with Early Breast Cancer
- (2013) Soo Jung Lee et al. ANNALS OF SURGICAL ONCOLOGY
- Fibrotic Focus in Breast Carcinomas: Relationship with Prognostic Parameters and Biomarkers
- (2013) S. Shafaq Mujtaba et al. ANNALS OF SURGICAL ONCOLOGY
- Ductal carcinomain situof the breast: morphological and molecular features implicated in progression
- (2013) Dirce M. Carraro et al. BIOSCIENCE REPORTS
- Adiponectin pathway polymorphisms and risk of breast cancer in African Americans and Hispanics in the Women’s Health Initiative
- (2013) Virginia G. Kaklamani et al. BREAST CANCER RESEARCH AND TREATMENT
- High expression of ATP-binding cassette transporter ABCC11 in breast tumors is associated with aggressive subtypes and low disease-free survival
- (2013) Akimitsu Yamada et al. BREAST CANCER RESEARCH AND TREATMENT
- Invasive ductal carcinoma with lobular features: a comparison study to invasive ductal and invasive lobular carcinomas of the breast
- (2013) David P. Arps et al. BREAST CANCER RESEARCH AND TREATMENT
- Synergy between chemotherapeutic agents and CTLA-4 blockade in preclinical tumor models
- (2013) Maria Jure-Kunkel et al. CANCER IMMUNOLOGY IMMUNOTHERAPY
- Lipid Metabolism Genes in Contralateral Unaffected Breast and Estrogen Receptor Status of Breast Cancer
- (2013) J. Wang et al. Cancer Prevention Research
- Prognostic and Predictive Value of Tumor-Infiltrating Lymphocytes in a Phase III Randomized Adjuvant Breast Cancer Trial in Node-Positive Breast Cancer Comparing the Addition of Docetaxel to Doxorubicin With Doxorubicin-Based Chemotherapy: BIG 02-98
- (2013) Sherene Loi et al. JOURNAL OF CLINICAL ONCOLOGY
- Aquaporin Water Channels in the Mammary Gland: From Physiology to Pathophysiology and Neoplasia
- (2013) Ali Mobasheri et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- Cancer Digital Slide Archive: an informatics resource to support integrated in silico analysis of TCGA pathology data
- (2013) David A Gutman et al. JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION
- Mutational heterogeneity in cancer and the search for new cancer-associated genes
- (2013) Michael S. Lawrence et al. NATURE
- Enriching the gene set analysis of genome-wide data by incorporating directionality of gene expression and combining statistical hypotheses and methods
- (2013) Leif Väremo et al. NUCLEIC ACIDS RESEARCH
- The expression profile of ATP-binding cassette transporter genes in breast carcinoma
- (2013) Viktor Hlaváč et al. PHARMACOGENOMICS
- Significance Analysis of Prognostic Signatures
- (2013) Andrew H. Beck et al. PLoS Computational Biology
- Molecular Pathology of Breast Cancer
- (2012) Kimberly H. Allison AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Concomitant Targeting of Tumor Cells and Induction of T-cell Response Synergizes to Effectively Inhibit Trastuzumab-Resistant Breast Cancer
- (2012) Q. Wang et al. CANCER RESEARCH
- A 50-Gene Intrinsic Subtype Classifier for Prognosis and Prediction of Benefit from Adjuvant Tamoxifen
- (2012) S. K. Chia et al. CLINICAL CANCER RESEARCH
- Targeting Chk1 in p53-deficient triple-negative breast cancer is therapeutically beneficial in human-in-mouse tumor models
- (2012) Cynthia X. Ma et al. JOURNAL OF CLINICAL INVESTIGATION
- Impaired Mitochondrial Metabolism and Mammary Carcinogenesis
- (2012) Nagendra Yadava et al. JOURNAL OF MAMMARY GLAND BIOLOGY AND NEOPLASIA
- The GP2 peptide: A HER2/neu-based breast cancer vaccine
- (2012) Kevin S. Clive et al. JOURNAL OF SURGICAL ONCOLOGY
- A Three-Gene Model to Robustly Identify Breast Cancer Molecular Subtypes
- (2012) Benjamin Haibe-Kains et al. JNCI-Journal of the National Cancer Institute
- The MYC-Associated Protein CDCA7 Is Phosphorylated by AKT To Regulate MYC-Dependent Apoptosis and Transformation
- (2012) R. Montgomery Gill et al. MOLECULAR AND CELLULAR BIOLOGY
- Comprehensive molecular portraits of human breast tumours
- (2012) Daniel C. Koboldt et al. NATURE
- DNA methylation profiling reveals a predominant immune component in breast cancers
- (2011) Sarah Dedeurwaerder et al. EMBO Molecular Medicine
- A Genomic Predictor of Response and Survival Following Taxane-Anthracycline Chemotherapy for Invasive Breast Cancer
- (2011) Christos Hatzis JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Expression of Leptin, Leptin Receptor, Adiponectin, and Adiponectin Receptor in Ductal CarcinomaIn Situand Invasive Breast Cancer
- (2011) Young-Ju Jeong et al. Journal of Breast Cancer
- Aquaporins in human breast cancer: Identification and involvement in carcinogenesis of breast cancer
- (2011) Zhonghua Shi et al. JOURNAL OF SURGICAL ONCOLOGY
- Aquaporin-5: A Marker Protein for Proliferation and Migration of Human Breast Cancer Cells
- (2011) Hyun Jun Jung et al. PLoS One
- Anti-ErbB-2 mAb therapy requires type I and II interferons and synergizes with anti-PD-1 or anti-CD137 mAb therapy
- (2011) J. Stagg et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Most Random Gene Expression Signatures Are Significantly Associated with Breast Cancer Outcome
- (2011) David Venet et al. PLoS Computational Biology
- GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers
- (2011) Craig H Mermel et al. GENOME BIOLOGY
- Histological type and grade of breast cancer tumors by parity, age at birth, and time since birth: a register-based study in Norway
- (2010) Grethe Albrektsen et al. BMC CANCER
- A Comparison of PAM50 Intrinsic Subtyping with Immunohistochemistry and Clinical Prognostic Factors in Tamoxifen-Treated Estrogen Receptor-Positive Breast Cancer
- (2010) T. O. Nielsen et al. CLINICAL CANCER RESEARCH
- New Insights of CTLA-4 into Its Biological Function in Breast Cancer
- (2010) H. Mao et al. CURRENT CANCER DRUG TARGETS
- Histological types of breast cancer: How special are they?
- (2010) Britta Weigelt et al. Molecular Oncology
- Expression of matrix metalloproteinases (MMPs) in primary human breast cancer and breast cancer cell lines: New findings and review of the literature
- (2009) Andrea Köhrmann et al. BMC CANCER
- Supervised Risk Predictor of Breast Cancer Based on Intrinsic Subtypes
- (2009) Joel S. Parker et al. JOURNAL OF CLINICAL ONCOLOGY
- Tumor-Associated Lymphocytes As an Independent Predictor of Response to Neoadjuvant Chemotherapy in Breast Cancer
- (2009) Carsten Denkert et al. JOURNAL OF CLINICAL ONCOLOGY
- lumi: a pipeline for processing Illumina microarray
- (2008) P. Du et al. BIOINFORMATICS
- WGCNA: an R package for weighted correlation network analysis
- (2008) Peter Langfelder et al. BMC BIOINFORMATICS
- The Diasporin Pathway: a tumor progression-related transcriptional network that predicts breast cancer survival
- (2008) Nigel P. S. Crawford et al. CLINICAL & EXPERIMENTAL METASTASIS
- Biological Processes Associated with Breast Cancer Clinical Outcome Depend on the Molecular Subtypes
- (2008) C. Desmedt et al. CLINICAL CANCER RESEARCH
- In vitro and in vivo analysis of B-Myb in basal-like breast cancer
- (2008) A R Thorner et al. ONCOGENE
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search